Intracellular expression of antibody fragments directed against hiv reverse transcriptase prevents hiv infection in vitro

Nature Medicine

Volumn 1, Issue 7, 1995, Pages 667-672

  Maciejewskp, Jaroslaw P ^a   Weichold, Frank F ^a   Young, Neal S ^a   Cara, Andrea ^b   Zella, Davide ^b   Reitz, Marvin S ^b   Gallo, Robert C ^b  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; IMMUNOGLOBULIN; MESSENGER RNA; RNA; RNA DIRECTED DNA POLYMERASE; VIRUS DNA;

ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE TRANSFER; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNIZATION; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; IMMUNOPRECIPITATION; LONG TERMINAL REPEAT; LYMPHOCYTE; NORTHERN BLOTTING; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SOUTHERN BLOTTING; VIRUS REPLICATION;

GENE THERAPY; HIV ANTIBODIES; HIV INFECTIONS; HIV-1; HIV-1 REVERSE TRANSCRIPTASE; HIV-2; HUMAN; IMMUNOGLOBULINS, FAB; RECOMBINANT FUSION PROTEINS; RNA-DIRECTED DNA POLYMERASE; T-LYMPHOCYTES; TRANSFECTION; TUMOR CELLS, CULTURED; VIRUS REPLICATION;

EID: 0029064110     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm0795-667     Document Type: Article

References (41)

1. Baltimore, D. Intracellular immunization. Nature 335, 395-396 (1988).
2. Trono, D., Feinberg, M.B. and Baltimore, D. HIV-1 Gag mutants can dominantly interfere with the replication of the wild-type virus. Cell 59, 113-120(1989).
3. Sullenger, B.A., Gallardo, H.F., Ungers, G.E. and Gilboa, E. Overexpression of Tar sequences renders cells resistant to human immunodeficiency virus replication. Cell 63, 601-608 (1990).
4. Yu, M. et al A hairpin ribozyme inhibits expression of diverse strains of human immunodeficiency virus type 1. Proc. natn. Acad. Sci. U.S.A. 90, 6340-6344 (1993).
5. Sarver, N. et al. Ribozymes as potential anti-HIV-1 therapeutic agents. Science 247, 1222-1225 (1990).
6. Shimada, T.M. et al. Trial of antisense RNA inhibition of HIV replication and gene expression. Antiviral Chem. Chemother. 2, 133-142 (1991).
7. Caruso, M. and Klatzmann, D. Selective killing of CD4+ cells harboring a human immunodeficiency virus-inducible suicide gene prevents viral spread in an infected population. Proc. natn. Acad. Sci. U.S.A. 89, 182-186 (1992).
8. Travis, J. Putting antibodies to work inside cells. Science 261, 1114 (1993).
9. Carlson, J.R. A new means of inducibly inactivating a cellular protein. Molec. cell. Biol. 8, 2638-2646 (1988).
10. Biocca, S., Pierandrei-Amaldi, P., Campioni, N. and Cattaneo, A, Intracellular immunization with cytosolic recombinant antibodies. BioTechnology 12, 396-399 (1984).
11. Tavladoraki, P., Benvenuto, S.T., De Martinis, D., Cattaneo, A. and Galeffi, P. Transgenic plants expressing a functional single-chain Fv antibody are specifically protected from virus attack. Nature 366, 469-472 (1993).
12. Marasco, W.A., Haseltine, W.A. and Chen, S.Y. Design, intracellular expression, and activity of a human anti-human immunodeficiency virus type 1 gpl20 single-chain antibody, Proc. natn. Acad. Sci. U.S.A. 90, 7427-7429 (1993).
13. Duan, L., Bagasra, O., Laughlin, M.A., Oakes, J.W. and Pomerantz, R.I. Potent inhibition of human immunodeficiency virus type 1 replication by an intracellular anti-Rev single chain antibody. Proc. natn. Acad. Sci. U.S.A. 91, 5015-5019 (1994).
14. Mullinax, R.L. et al Identification of human antibody fragment clones specific for tetanus toxoid in a bacteriophage lambda immunoexpression library. Proc. natn. Acad. Sci. U.S.A. 87, 8095-8099 (1990).
15. Huse, W.D. et al Generation of a large combinational library of the immunoglobulin repertoire in phage lambda. Science 246, 1275-1281 (1989).
16. Pluckthun, A. Antibody engineering: Advances from the use of Escherichia coli expression systems. BioTechnology 9, 545-551 (1991).
17. DiMarzo Veronese, F. et al Characterization of highly immunogenic p55/p66 as the reverse transcriptase of HTLV-III/LAV. Science 231, 1289-1291 (1976)
18. Yates, J., Warren, N. and Sugden, B. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature 313, 812-815 (1985).
19. Hambor, J.E. et al. Use of an Epstein-Barr virus episomal replicón for antisense RNA-mediated gene inhibition in a human cytotoxic T-cell clone. Proc. natn. Acad. Sci. U.S.A. 85, 4010-4014 (1988).
20. Young, J.M. et al. Utilization of Epstein-Barr vims replicón as a eukaryotic expression vector. Gene 62, 171-185 (1988).
21. Groger, R.K., Morrow, D.M. and Tykocinski, M.L. Directional antisense and sense cloning using Epstein-Barr vims episomal expression vectors. Gene 81, 285-294 (1989).
22. Karin, M. et al Characterization of DNA sequences through which cadmium and glucocorticoid hormones induce human metallothionein-IlA gene. Nature SOS, 513-519 (1984).
23. Pauwels, R. et al. Rapid and automated tetrazolium-based assay for the detection of anti-HIV compounds. J. virol. Meth. 20, 309-321 (1988).
24. Gerna, G. et al. Effect of Foscarnet induction treatment on the quantitation of human cytomegalovirus (HCMV) DNA in peripheral blood polymorphonuclear leucocytes and aqueous humor of AIDS patients with HCMV retinitis. Antimicrob. Agents Chemother. 38, 38-44 (1984).
25. Ou, C.-Y. et al, DNA amplification for direct detection of HIV-1 In DNA of peripheral blood mononuclear cells. Science 239, 295-297 (1988).
26. Lori, F. et al. Viral DNA carried by human immunodeficiency virus type 1 virions. J. Virol 66, 5067-5074 (1992).
27. Cara, A., Guarnaccia, F., Reitz, M.S., Gallo, R.C. and Lori, F. Self limiting, cell type dependent replication of an integrase-defective HIV-1 in primary macrophages, but not T-lymphocytes. Virology 208, 242-248 (1995).
28. Zack, J.A. et al. HIV-1 entry into quiescent primary lymphocytes: Molecular analysis reveals a labile latent viral structure. Cell 61, 213-222 (1990).
29. Bukrinsky, D. et al. Active nuclear transport of human immunodeficiency virus type 1 preintegration complexes Proc. natn. Acad. Sci U.S.A. 89, 6580-6584 (1992).
30. Peng, L. et al. initiation of reverse transcription during cell-to-cell transmission of human immunodeficiency virus infection uses pre-existing reverse transcriptase. J. gen. Virol 75, 1917-1926 (1994)
31. Withlow, M. and Filpula, D. Single-chain Fv proteins and their fusion proteins. Meth. Enzym. 2, 97-105 (1991).
32. Huston, J. S. et al. Protein engineering of antibody binding sites: Recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coll Proc. natn. Acad. Sci. U.S.A. 85, 5879-5883 (1988).
33. Tai, M.-S. et al A bifunctional fusion protein containing Fc-binding Fragment of staphylococcal protein A amino terminal to antidigoxin single-chain Fv. Biochemistry 29, 8024-8030 (1990).
34. Gilboa, E., Eglitis, M.A., Kantoff, P.W. and Anderson, F. Transfer and expression of cloned genes using retroviral vectors. BioTechniques 4, 584-612 (1986).
35. Tratschin, J.-D., Miller, I.L., Smith, M.G. and Carter, B.J. Adeno-associated virus vector for high-frequency integration, expression and rescue of genes in mammalian cells. Molec. cell. Biol 5, 3251-3260, (1985).
36. Woffendin, C. et al. Nonviral and viral delivery of a human immunodeficiency virus protective gene into primary human T cells. Proc. natn. Acad. Sei. U.S.A. 91, 11581-11585 (1994).
37. Muro-Cacho, C.A., Samulski, R-J. and Kaplan, D. Gene transfer in human lymphocytes using a vector based on adeno-associated virus. J. Immunother. 11, 231-237 (1992).
38. Dunbar, C.E. and Emmons, R.V.B. Gene transfer into hematopoietic progenitor and stem cells: Progress and problems. Stem Cells 12, 563-576 (1994).
39. Dunbar, C.E. et al Retrovirally-marked CD34-enriched blood and bone marrow cells contribute to long-term engraftment after autologous transplantation. Blood (in the press).
40. Brenner, M.K. et al. Gene-marking to trace origin of after autologous bone marrow transplantation. Lancet 341, 85-90 (1993)
41. Talbott, R., Krous, G., Looney, D. and Wong-Staal, F. Mapping the determinants of human immunodeficiency virus-2 for infectivity, replication efficiency, and cytopathicity. Proc. natn. Acad. Sci. U.S.A. 90, 4226-4229 (1993).